Navigation Links
Hawkins, Inc. Declares Semi-Annual Cash Dividend Of $0.34 Per Share
Date:8/2/2012

MINNEAPOLIS, Aug. 2, 2012 /PRNewswire/ -- The Board of Directors of Hawkins, Inc. (Nasdaq:   HWKN), at its meeting on August 2, 2012, declared a semi-annual cash dividend of $0.34 per share payable October 5, 2012, to shareholders of record at the close of business on September 21, 2012.  This is the 27th consecutive year the Company has paid cash dividends since it first began paying out dividends in 1985.

Hawkins, Inc. distributes, blends and manufactures bulk and specialty chemicals for its customers in a wide variety of industries. Headquartered in Minneapolis, Minnesota, and with 25 facilities in 13 states, the Company creates value for its customers through superb customer service and support, quality products and personalized applications.


'/>"/>
SOURCE Hawkins, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
2. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
3. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend
4. BD Board Declares Dividend
5. Hill-Rom Announces Third Quarter 2012 Dividend
6. Heska Announces Quarterly Dividend of $0.10 Per Share
7. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
8. Zimmer Announces Quarterly Dividend for Second Quarter of 2012
9. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
10. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
11. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):